Paper30739747
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.
Hanley DF and 52 others. Lancet, 2019. Cited by 761 papers, by iCite.
Cite this record
ConductScience Library. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Papers, record 30739747. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30739747
- Disease
- stroke disorder228 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.
- PubMed
- Publication types
- Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial
- PubMed
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cerebral Hemorrhage | Major topic |
| Minimally Invasive Surgical Procedures | Major topic |
| Thrombolytic Therapy | Major topic |
| Aged | |
| Female | |
| Humans | |
| Intention to Treat Analysis | |
| Male | |
| Middle Aged | |
| Treatment Outcome |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U01 NS080824 | NINDS NIH HHS | United States | U01NS080824 | PubMed and NIH |
Source NIH RePORTER
Trials10
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01827046 | Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT03899350 | The Influencing Factors and Prediction Model of Poor Prognosis of Spontaneous Intraparenchymal Hemorrhage | Background | ClinicalTrials.gov | |
| NCT04172376 | Stereotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation II | Background | ClinicalTrials.gov | |
| NCT04200781 | Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke | Results | ClinicalTrials.gov | |
| NCT05538286 | Transcranial Ultrasound Via Sonolucent Cranioplasty After Minimally Invasive Intracerebral Hemorrhage Evacuation | Background | ClinicalTrials.gov | |
| NCT06668441 | Minimally Invasive Surgery and rhTNK-tPA for Intracerebral Hemorrhage Evacuation | Results | ClinicalTrials.gov | |
| NCT06862388 | Stem Cell Therapy for Intracerebral Hemorrhage | Results | ClinicalTrials.gov | |
| NCT06894433 | Efficacy and Safety of NeuroEndoscopic Surgery for Large IntraCerebral Hemorrhage | Background | ClinicalTrials.gov | |
| NCT07641998 | Robot-Assisted Hematoma Evacuation With Intrahematoma Tenecteplase for Post-Reperfusion PH2 Hemorrhagic Transformation | Background | ClinicalTrials.gov | |
| NCT07710313 | Minimally Invasive Surgery for Spontaneous Deep Intracerebral Hemorrhage | Background | ClinicalTrials.gov |
Comments and corrections5
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Erratum in | 31007203 | Department of Error. | https://conductscience.org/library/papers/31007203 | PubMed |
| Comment in | 30739746 | Minimally invasive surgery plus alteplase for intracerebral haemorrhage. | https://conductscience.org/library/papers/30739746 | PubMed |
| Comment in | 31448742 | Surgery for intracerebral haemorrhage. | https://conductscience.org/library/papers/31448742 | PubMed |
| Comment in | 31448743 | Surgery for intracerebral haemorrhage. | https://conductscience.org/library/papers/31448743 | PubMed |
| Comment in | 31960045 | Commentary: Efficacy and Safety of Minimally Invasive Surgery With Thrombolysis in Intracerebral Haemorrhage Evacuation (MISTIE III): A Randomized, Controlled, Open-Label, Blinded Endpoint Phase 3 Trial. | https://conductscience.org/library/papers/31960045 | PubMed |
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23726393 | Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. | Lancet | 2013 | https://conductscience.org/library/papers/23726393 | PubMed |
| 2 | 22989500 | Minimally invasive surgery for spontaneous supratentorial intracerebral hemorrhage: a meta-analysis of randomized controlled trials. | Stroke | 2012 | https://conductscience.org/library/papers/22989500 | PubMed |
| 3 | 23713578 | Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23713578 | PubMed |
| 4 | 28081952 | Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. | Lancet | 2017 | https://conductscience.org/library/papers/28081952 | PubMed |
| 5 | 24052508 | Improving the efficiency of stroke trials: feasibility and efficacy of group adjudication of functional end points. | Stroke | 2013 | https://conductscience.org/library/papers/24052508 | PubMed |
| 6 | 27751554 | Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. | Lancet Neurol | 2016 | https://conductscience.org/library/papers/27751554 | PubMed |
| 7 | 22611591 | Targeted minimum loss based estimation of causal effects of multiple time point interventions. | Int J Biostat | 2012 | https://conductscience.org/library/papers/22611591 | PubMed |
| 8 | 10753984 | Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma : protocol and preliminary experience. | Stroke | 2000 | https://conductscience.org/library/papers/10753984 | PubMed |
| 9 | 18480205 | Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18480205 | PubMed |
| 10 | 15728810 | Recombinant activated factor VII for acute intracerebral hemorrhage. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15728810 | PubMed |
| 11 | 27322807 | The Safety and Feasibility of Image-Guided BrainPath-Mediated Transsulcul Hematoma Evacuation: A Multicenter Study. | Neurosurgery | 2017 | https://conductscience.org/library/papers/27322807 | PubMed |
| 12 | 20470370 | The health loss from ischemic stroke and intracerebral hemorrhage: evidence from the North East Melbourne Stroke Incidence Study (NEMESIS). | Health Qual Life Outcomes | 2010 | https://conductscience.org/library/papers/20470370 | PubMed |
| 13 | 20651276 | Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. | Stroke | 2010 | https://conductscience.org/library/papers/20651276 | PubMed |
| 14 | 25177839 | Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients with intracerebral haemorrhage. | Cochrane Database Syst Rev | 2014 | https://conductscience.org/library/papers/25177839 | PubMed |
| 15 | 28626061 | Intensive Blood Pressure Lowering in Intracerebral Hemorrhage. | Stroke | 2017 | https://conductscience.org/library/papers/28626061 | PubMed |
| 16 | 20636706 | Stroke: working toward a prioritized world agenda. | Int J Stroke | 2010 | https://conductscience.org/library/papers/20636706 | PubMed |
| 17 | 19236490 | Minimally invasive craniopuncture therapy vs. conservative treatment for spontaneous intracerebral hemorrhage: results from a randomized clinical trial in China. | Int J Stroke | 2009 | https://conductscience.org/library/papers/19236490 | PubMed |
| 18 | 29096678 | Minimal sufficient balance randomization for sequential randomized controlled trial designs: results from the ESCAPE trial. | Trials | 2017 | https://conductscience.org/library/papers/29096678 | PubMed |
| 19 | 25104492 | Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. | Lancet Glob Health | 2013 | https://conductscience.org/library/papers/25104492 | PubMed |
| 20 | 25395503 | Explanatory trials versus pragmatic trials. | BMJ | 2014 | https://conductscience.org/library/papers/25395503 | PubMed |
Cited by497
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 761 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958483 | Risk factors of recurrent hemorrhage following minimally invasive transcranial puncture and drainage in patients with spontaneous intracerebral hemorrhage: a retrospective cohort study. | BMC Neurol | 2026 | https://conductscience.org/library/papers/42958483 | PubMed |
| 42955569 | Farrerol Attenuates Brain Injury After Intracerebral Hemorrhage and Modulates Nrf2 and TLR4/NF-κB Signaling. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42955569 | PubMed |
| 42953864 | Foley Catheter-Assisted Evacuation of Clot Versus Conventional Craniotomy for Spontaneous Supratentorial Intracerebral Haemorrhage: A Single-Centre Observational Study. | Malays J Med Sci | 2026 | https://conductscience.org/library/papers/42953864 | PubMed |
| 42949837 | Functional trajectories between 90 days and 1 year after intracerebral haemorrhage: a Swedish Stroke Register (Riksstroke) study. | Eur Stroke J | 2026 | https://conductscience.org/library/papers/42949837 | PubMed |
| 42946955 | High Postoperative Perihematomal Edema Trajectory after Endoscopic Evacuation for Supratentorial Intracerebral Hemorrhage. | Neurocrit Care | 2026 | https://conductscience.org/library/papers/42946955 | PubMed |
| 42946870 | Comparison of rebleeding risk after navigation-guided catheterization and thrombolytic irrigation using tPA or urokinase in intracerebral hemorrhage. | Acta Neurochir (Wien) | 2026 | https://conductscience.org/library/papers/42946870 | PubMed |
| 42877430 | Development and Validation of a Human Cadaveric Model for Lobar Intracerebral Hemorrhage. | Neurosurg Pract | 2026 | https://conductscience.org/library/papers/42877430 | PubMed |
| 42867108 | Admission White Blood Cell Count and Neutrophil-to-Lymphocyte Ratio for Early Risk Stratification after Spontaneous Intracerebral Hemorrhage: A Retrospective Cohort Study. | Brain Behav | 2026 | https://conductscience.org/library/papers/42867108 | PubMed |
| 42855245 | Evaluation of methodology, reporting and transparency of 50 highly cited randomised trials in neurology: a cross-sectional analysis. | BMJ Open | 2026 | https://conductscience.org/library/papers/42855245 | PubMed |
| 42768267 | Extension of the FUNC Score for Prediction of 12-Month Functional Independence after Primary Intracerebral Hemorrhage. | Neurocrit Care | 2026 | https://conductscience.org/library/papers/42768267 | PubMed |
| 42768231 | Analysis of influencing factors in patients with hypertensive intracerebral hemorrhage in the basal ganglia region treated with stereotactic surgery. | Neurosurg Rev | 2026 | https://conductscience.org/library/papers/42768231 | PubMed |
| 42747864 | Efficacy and safety of minocycline in the treatment of intracerebral haemorrhage: study design and protocol for a multicentre, randomised, open-label, blinded endpoint clinical trial. | Eur Stroke J | 2026 | https://conductscience.org/library/papers/42747864 | PubMed |
| 42746064 | Stereotactic Hematoma Aspiration Versus Standard Treatment for Brainstem Hemorrhage-Updated Meta-Analysis, Meta-Regression, and Trial Sequential Analysis. | Stroke Res Treat | 2026 | https://conductscience.org/library/papers/42746064 | PubMed |
| 42689324 | Cilostazol Treatment for Intracerebral Hemorrhage: Targeting Dural Lymphatics. | Stroke | 2026 | https://conductscience.org/library/papers/42689324 | PubMed |
| 42658158 | The evolving landscape of stroke interventions. | Singapore Med J | 2026 | https://conductscience.org/library/papers/42658158 | PubMed |
| 42625575 | The identification of white matter fibers in the hematoma of intracerebral hemorrhage patients. | Front Cell Neurosci | 2026 | https://conductscience.org/library/papers/42625575 | PubMed |
| 42614549 | Trans-sylvian hematoma evacuation combined with lamina terminalis ventriculostomy for hypertensive basal ganglia hemorrhage: a retrospective cohort study. | Front Surg | 2026 | https://conductscience.org/library/papers/42614549 | PubMed |
| 42610031 | Investigating Intracerebral Hemorrhage Evacuation Procedure Volumes Before and After the Minimally Invasive Surgery Plus Alteplase for Intracerebral Hemorrhage Evacuation III (MISTIE III) Trial. | Cureus | 2026 | https://conductscience.org/library/papers/42610031 | PubMed |
| 42609371 | Efficacy of rt-PA versus Urokinase in early time windows for minimally invasive intracerebral hemorrhage evacuation and exploratory TAFI pharmacogenomics. | Front Neurol | 2026 | https://conductscience.org/library/papers/42609371 | PubMed |
| 42607002 | Motor Impairment Is the Key Determinant of the 1-Year Modified Rankin Scale Score in Intracerebral Haemorrhage. | Cerebrovasc Dis | 2026 | https://conductscience.org/library/papers/42607002 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| F2 | 2147 | PubTator's text mining | https://conductscience.org/library/genes/2147 |
Source NCBI Gene
Drugs2
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| ALTEPLASE | CHEMBL1201593 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1201593 | ChEMBL |
| TENECTEPLASE | CHEMBL2108791 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL2108791 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30739747
GET https://conductscience.org/api/papers/v1/30739747/authors?page=2